Eli Lilly

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Eli Lilly and other ETFs, options, and stocks.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.

CEO

David A. Ricks

CEODavid A. Ricks

Employees

39,000

Employees39,000

Headquarters

Indianapolis, Indiana

HeadquartersIndianapolis, Indiana

Founded

1876

Founded1876

Employees

39,000

Employees39,000

LLY Key Statistics

Market cap

404.14B

Market cap404.14B

Price-Earnings ratio

68.79

Price-Earnings ratio68.79

Dividend yield

0.96%

Dividend yield0.96%

Average volume

2.96M

Average volume2.96M

High today

$431.67

High today$431.67

Low today

$423.67

Low today$423.67

Open price

$425.38

Open price$425.38

Volume

2.21M

Volume2.21M

52 Week high

$454.95

52 Week high$454.95

52 Week low

$283.11

52 Week low$283.11

LLY News

Yahoo Finance 3h

Calculating The Intrinsic Value Of Eli Lilly and Company - Yahoo Finance

Key Insights Using the 2 Stage Free Cash Flow to Equity, Eli Lilly fair value estimate is US$373 Current share price of US$426 suggests Eli Lilly is potential...

Investor's Business Daily 2d

Eli Lilly Could Launch Its Rival To Novo Nordisk's Weight-Loss Drug A Year Earlier Than Expected

An analyst expects Eli Lilly (LLY) to launch a competitor to weight-loss drugs from Novo Nordisk (NVO) in 2026 — a year earlier than expected — giving Eli Lilly...

Benzinga 3d

$100 Invested In This Stock 20 Years Ago Would Be Worth $700 Today - Eli Lilly - Benzinga

Eli Lilly LLY has outperformed the market over the past 20 years by 2.83% on an annualized basis producing an average annual return of 10.33%. Currently, Eli Li...

Analyst ratings

71%

of 24 ratings

Buy

70.8%

Hold

20.8%

Sell

8.3%

LLY Earnings

$0.00

$0.87

$1.75

$2.62

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Q1 FY23

Q2 FY23

Estimated

— per share

Estimated— per share

Actual

Available Aug 8, Pre-Market

ActualAvailable Aug 8, Pre-Market

More LLY News

Simply Wall St 3d

Eli Lilly Has A Pretty Healthy Balance Sheet

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the vol...

CNBC 4d

Bank of America boosts price target on Eli Lilly to $500 on obesity drug demand - CNBC

Eli Lilly shares could jump as interest rises in obesity drug tirzepatide, according to Bank of America. Analyst Geoff Meacham reiterated his buy rating on the...

Benzinga 5d

Eli Lilly Unusual Options Activity For May 23 - Eli Lilly - Benzinga

Someone with a lot of money to spend has taken a bearish stance on Eli Lilly LLY. And retail traders should know. We noticed this today when the big position...

CNBC 5d

Cramer says AI is fueling the 'reacceleration of tech' in the stock market - CNBC

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a recap of Tuesday's key moments. 'Sitting i...

Yahoo Finance 5d

Hers’s Why Eli Lilly and Company Declined in Q1 - Yahoo Finance

Fred Alger Management, an investment management company, released its “Alger Spectra Fund” first quarter 2023 investor letter. A copy of the same can be downloa...

CNBC 6d

Another all-time high gives us runway to take big profits in a drug ... - CNBC

We are selling 50 shares of Eli Lilly (LLY) at roughly $442 each. Following Monday's trade, Jim Cramer's Charitable Trust will own 150 shares of LLY, decreasing...

Yahoo Finance 6d

Lilly ESG Report Highlights Progress Towards Sustainability Goals - Yahoo Finance

Reduced greenhouse gas emissions by 20% Improved access to Lilly insulins in the U.S. Nearly doubled patients reached in resource-limited settings through...